Physician profile
Charlott Barron
NPI 1952052680
$1,008.48
in general payments reported to CMS, 2019-2025
10 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $357 · 2024: $451 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $334.53 | 2024 | Gammagard, Entyvio |
| Amgen INC. | $128.02 | 2025 | |
| Horizon Therapeutics Plc | $124.67 | 2023 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $117.23 | 2023 | Ultomiris |
| Astrazeneca Pharmaceuticals Lp | $116.15 | 2024 | Saphnelo |
| Tg Therapeutics, INC. | $100.55 | 2023 | |
| Abbvie INC. | $29.27 | 2025 | |
| Geron Corporation | $25.80 | 2025 | Rytelo |
| Grifols USA, LLC | $17.38 | 2025 | Prolastin-C Liquid |
| Eisai INC. | $14.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlott Barron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.